Antimicrobial resistance (AMR) presents a formidable global health and development challenge, making collaboration between researchers and policymakers not only beneficial–but essential.
Each year millions of people are killed or injured by AMR and its impact is not limited to human health. AMR poses a significant threat to progress on most of the United Nations Sustainable Development Goals, including SDG 2-Zero Hunger, SDG 6-Clean Water and Sanitation and SDG 13– Climate Action.
At the same time, new AMR research and data that could inform better AMR policy becomes available weekly. It is crucial to facilitate pathways between researchers and policymakers to ensure high quality and context-specific AMR research can be used to inform the creation, updating, and implementation of AMR policies. By taking this scientific approach, policies are more likely to be effective and less costly since they are based on what has been shown to work.
In a recent webinar, our panel of researchers and policy experts delved into the challenges and opportunities for evidence-informed AMR policymaking during a 1-hour session.
- Dr A. M. Viens
- Dr. Ifedayo Adetifa, Nigeria Centre for Disease Control and Prevention
- Professor Clare Chandler, London School of Hygiene & Tropical Medicine
- Dr. Susan Rogers Van Katwyk, AMR Policy Accelerator
- Dr. Zubin Shroff, Alliance for Health Policy and Systems Research